NIH-funded research R01 grant

Understanding how high homocysteine levels worsen brain injury after a stroke

Official title: Molecular basis of hyperhomocysteinemia induced brain injury in ischemic stroke

Funded at University of New Mexico Health Scis Ctr · NIH-10802414 · Data updated 2026-11-12

This research looks at how high levels of a substance called homocysteine in the blood might make brain damage worse for people who have had an ischemic stroke.

More Stroke research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of New Mexico Health Scis Ctr
NIH-funded
Lab location1 site (Albuquerque, United States)
Project startMay 1, 2014
Project endAugust 31, 2026
Funding year2025
Award (this year)$520,189
NIH project number5R01NS083914-10
Project IDNIH-10802414 on NIH RePORTER

Who could benefit from this research

Could help

This foundational research is for patients who have experienced an ischemic stroke and also have high levels of homocysteine in their blood.

Less likely to help

Patients whose strokes are not related to high homocysteine levels may not directly benefit from this specific line of research.

What this research studies

Many older adults have high homocysteine levels, even with folic acid in food, often due to changes in nutrition and metabolism as they age. While we know high homocysteine is linked to neurological problems, we don't fully understand how it directly affects stroke outcomes. This project aims to uncover a specific brain signaling pathway that appears to make stroke injury more severe when homocysteine levels are high. Our goal is to find new ways to protect the brain from damage in people who experience a stroke with high homocysteine.

Why it matters

Potential benefit: If successful, this work could lead to new treatments that reduce brain damage and improve recovery for stroke patients with high homocysteine levels.

How similar studies have gone: Previous findings from this team suggest a novel signaling pathway is involved, building upon existing knowledge that high homocysteine is a risk factor for neurological diseases.

Where this research is happening

  • University of New Mexico Health Scis Ctr
    Albuquerque, United States
    Active

Researchers

  • Principal investigator: Poddar, Ranjana — University of New Mexico Health Scis Ctr
  • Study coordinator: Poddar, Ranjana

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.